Xu, F., Shen, G., Su, Z., He, Z., & Yuan, L. (2019). Glibenclamide ameliorates the disrupted blood–brain barrier in experimental intracerebral hemorrhage by inhibiting the activation of NLRP3 inflammasome. Brain Behav.
Chicago-стиль цитированияXu, Fulin, Gang Shen, Zuopeng Su, Zijian He, and Lutao Yuan. "Glibenclamide Ameliorates the Disrupted Blood–brain Barrier in Experimental Intracerebral Hemorrhage By Inhibiting the Activation of NLRP3 Inflammasome." Brain Behav 2019.
MLA-цитированиеXu, Fulin, et al. "Glibenclamide Ameliorates the Disrupted Blood–brain Barrier in Experimental Intracerebral Hemorrhage By Inhibiting the Activation of NLRP3 Inflammasome." Brain Behav 2019.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.